(Q38209857)

31 August 2017

title

Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature (English)

1 reference

31 August 2017

0 references

1 reference

Esmée M S Vural

1

1 reference

31 August 2017

Barbara C van Munster

series ordinal

2

1 reference

31 August 2017

Sophia E de Rooij

series ordinal

3

1 reference

31 August 2017

publication date

1 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

31

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

441-451

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

31 August 2017

1 reference

Daily rhythm in human urinary melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

The relationship between 6-sulphatoxymelatonin rhythm phase and age in self-reported good sleeping controls and sleep maintenance insomniacs aged 55-80 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Sleep disorders and melatonin rhythms in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Postoperative delirium and melatonin levels in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Melatonin decreases delirium in elderly patients: A randomized, placebo‐controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Effect of pharmacological daytime doses of melatonin on human mood and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

A three pulse phase response curve to three milligrams of melatonin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Loss of response to melatonin treatment is associated with slow melatonin metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Plasma concentrations of melatonin in man following oral absorption of different preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Feasibility and functionality of OROS melatonin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

The use of high-dose melatonin in liver resection is safe: first clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Antioxidative effects of melatonin administration in elderly primary essential hypertension patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Pharmacokinetics of orally administered melatonin in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Effects of melatonin and rilmazafone on nocturia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Melatonin treatment for age-related insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Melatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0178-0

Plasma melatonin rhythms in young and older humans during sleep, sleep deprivation, and wake

21 January 2018

1 reference

12 December 2020

Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2

1 reference

12 December 2020

Endogenous Melatonin Levels and the Fate of Exogenous Melatonin: Age Effects

1 reference

12 December 2020

Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal

1 reference

12 December 2020

Some effects of melatonin and the control of its secretion in humans

1 reference

12 December 2020

A double-blind placebo-controlled randomised pilot study of nocturnal melatonin in tracheostomised patients.

1 reference

12 December 2020

Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans

1 reference

12 December 2020

Alterations in Nocturnal Serum Melatonin Levels In Humans With Growth and Aging*

1 reference

12 December 2020

Effects of daytime melatonin infusion in young adults

1 reference

12 December 2020

Melatonin is able to influence its secretion in humans: description of a phase-response curve

1 reference

12 December 2020

Effects of a four-day nocturnal melatonin treatment on the 24 h plasma melatonin, cortisol and prolactin profiles in humans

1 reference

12 December 2020

The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light

1 reference

12 December 2020

Bioavailability of melatonin in humans after day-time administration of D(7) melatonin

1 reference

12 December 2020

The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement

1 reference

12 December 2020

Time dependent effect of melatonin administration on lipid peroxidation, superoxide dismutase activity and melatonin concentration in the elderly patients with essential arterial hypertension

1 reference

12 December 2020

Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study

1 reference

12 December 2020

10.1007/S40266-014-0178-0

Identifiers

DOI

1 reference

31 August 2017

1 reference